Tau polymerization: role of the amino terminus - PubMed (original) (raw)
. 2003 Feb 25;42(7):2252-7.
doi: 10.1021/bi0272510.
Affiliations
- PMID: 12590615
- DOI: 10.1021/bi0272510
Tau polymerization: role of the amino terminus
T Chris Gamblin et al. Biochemistry. 2003.
Abstract
The abnormal polymerization of the tau molecule into insoluble filaments is a seminal event in the neurodegenerative process underlying Alzheimer's disease. Previous experimentation has shown that the microtubule-binding repeat region of the molecule is vital for its ability to polymerize in vitro into filaments similar to those found in Alzheimer's disease. However, it is becoming clear that regions outside the microtubule-binding repeat, such as exons 2 and 3 and the carboxy-terminal tail, can greatly influence its polymerization. Since it has been previously postulated that the amino terminus of tau could be involved in generating pathological conformations in the disease state, its role in the polymerization process was investigated. This report demonstrates that the removal of the amino terminus greatly inhibits the polymerization of the tau molecule, reducing both the rate and extent of polymerization. These results support the hypothesis that the ability of tau to form specific conformations involving the amino terminus is an early event in the formation of tau polymers in the disease state. Furthermore, the mutation of arginine 5 to leucine ((R)5(L)), mimicking an amino-terminal tau mutation found in a single case of FTDP-17, enhances the polymerization of the tau molecule. Therefore, the amino terminus of the tau molecule, while largely overlooked in studies of its polymerization, is a significant contributor to the polymerization process.
Similar articles
- A complex mechanism for inducer mediated tau polymerization.
Carlson SW, Branden M, Voss K, Sun Q, Rankin CA, Gamblin TC. Carlson SW, et al. Biochemistry. 2007 Jul 31;46(30):8838-49. doi: 10.1021/bi700403a. Epub 2007 Jul 4. Biochemistry. 2007. PMID: 17608454 - Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment.
Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, Cryns VL, Binder LI. Berry RW, et al. Biochemistry. 2003 Jul 15;42(27):8325-31. doi: 10.1021/bi027348m. Biochemistry. 2003. PMID: 12846581 - Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro.
Yanagawa H, Chung SH, Ogawa Y, Sato K, Shibata-Seki T, Masai J, Ishiguro K. Yanagawa H, et al. Biochemistry. 1998 Feb 17;37(7):1979-88. doi: 10.1021/bi9724265. Biochemistry. 1998. PMID: 9485325 - Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein.
Dinoto L, Deture MA, Purich DL. Dinoto L, et al. Microsc Res Tech. 2005 Jul;67(3-4):156-63. doi: 10.1002/jemt.20195. Microsc Res Tech. 2005. PMID: 16104002 Review. - Evaluating triggers and enhancers of tau fibrillization.
Kuret J, Congdon EE, Li G, Yin H, Yu X, Zhong Q. Kuret J, et al. Microsc Res Tech. 2005 Jul;67(3-4):141-55. doi: 10.1002/jemt.20187. Microsc Res Tech. 2005. PMID: 16103995 Review.
Cited by
- Tau as a therapeutic target in neurodegenerative disease.
Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI. Himmelstein DS, et al. Pharmacol Ther. 2012 Oct;136(1):8-22. doi: 10.1016/j.pharmthera.2012.07.001. Epub 2012 Jul 10. Pharmacol Ther. 2012. PMID: 22790092 Free PMC article. Review. - Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.
Skrabana R, Sevcik J, Novak M. Skrabana R, et al. Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1085-97. doi: 10.1007/s10571-006-9083-3. Epub 2006 Jun 16. Cell Mol Neurobiol. 2006. PMID: 16779670 Free PMC article. Review. - The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.
LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, Brady ST. LaPointe NE, et al. J Neurosci Res. 2009 Feb;87(2):440-51. doi: 10.1002/jnr.21850. J Neurosci Res. 2009. PMID: 18798283 Free PMC article. - Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.
Combs B, Voss K, Gamblin TC. Combs B, et al. Biochemistry. 2011 Nov 8;50(44):9446-56. doi: 10.1021/bi2010569. Epub 2011 Oct 17. Biochemistry. 2011. PMID: 21942206 Free PMC article. - Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics.
Rosseels J, Van den Brande J, Violet M, Jacobs D, Grognet P, Lopez J, Huvent I, Caldara M, Swinnen E, Papegaey A, Caillierez R, Buée-Scherrer V, Engelborghs S, Lippens G, Colin M, Buée L, Galas MC, Vanmechelen E, Winderickx J. Rosseels J, et al. J Biol Chem. 2015 Feb 13;290(7):4059-74. doi: 10.1074/jbc.M114.627919. Epub 2014 Dec 24. J Biol Chem. 2015. PMID: 25540200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources